Doctor profile · Federal record
Dr. Gincy Samuel, MD
Neurology Physician (CMS: Neurology) · Dallas, TX
- NPI 1821298399
- Accepts Medicare
- 19 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6080 N Central Expy Ste 100
Dallas, TX 752065202
(214) 827-3610
fax (214) 821-4017
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- August 23, 2021
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- Texas #P3970
- Medicaid
- TX #304004001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1821298399. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
28,293
Distinct HCPCS
10
Medicare allowed
$241,270
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0585 |
Injection, onabotulinumtoxina, 1 unit | 18,805 | 35 | $6 | |
A9575 |
Injection, gadoterate meglumine, 0.1 ml | 8,610 | 49 | $0 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 421 | 193 | $126 | |
64615 |
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 114 | 36 | $150 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 61 | 61 | $165 | |
70553 |
Mri scan of brain before and after contrast | 40 | 40 | $228 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 40 | 36 | $178 | |
64400 |
Injection of anesthetic agent and/or steroid into face nerve | 26 | 18 | $145 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 25 | 25 | $212 | |
96372 |
Injection of drug or substance under skin or into muscle | 21 | 15 | $14 |
In context: peer comparison
Among 41 peers in Dallas Neurology Physician, average services per provider: 1,234. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$9,249
Transactions
111
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 21 | $5,538.30 | |
| Lundbeck LLC | 13 | $1,625.78 | |
| Argenx US, INC. | 11 | $268.55 | |
| Ucb, INC. | 10 | $199.23 | |
| Teva Pharmaceuticals USA, INC. | 8 | $190.71 | |
| Alexion Pharmaceuticals, INC. | 7 | $185.47 | |
| Acadia Pharmaceuticals INC | 7 | $171.12 | |
| Merz Pharmaceuticals, LLC | 4 | $130.34 | |
| Lilly USA, LLC | 7 | $130.21 | |
| Eisai INC. | 5 | $128.09 | |
| Neurocrine Biosciences, INC. | 3 | $93.10 | |
| Novartis Pharmaceuticals Corporation | 5 | $76.28 | |
| Genentech USA, INC. | 3 | $67.05 | |
| Tg Therapeutics, INC. | 3 | $64.83 | |
| Pfizer INC. | 4 | $63.97 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
813
Patients
210
Total drug cost
$200,800
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Donepezil Hcl | Generic | 169 | 58 | $4,168 |
| Gabapentin | Generic | 127 | 53 | $2,916 |
| Memantine Hcl | Generic | 115 | 35 | $4,497 |
| Emgality Pen (Galcanezumab-Gnlm) | Brand | 101 | 19 | $78,862 |
| Levetiracetam | Generic | 39 | 0 | $1,475 |
| Sumatriptan Succinate | Generic | 33 | 12 | $1,815 |
| Oxcarbazepine | Generic | 30 | 0 | $1,884 |
| Topiramate | Generic | 28 | 0 | $353 |
| Ubrelvy (Ubrogepant) | Brand | 27 | 15 | $33,734 |
| Aimovig Autoinjector (Erenumab-Aooe) | Brand | 26 | 0 | $24,959 |
Frequently asked questions
What is Dr. Gincy Samuel's medical specialty?
Dr. Gincy Samuel practices Neurology Physician in Dallas, TX.
Where does Dr. Gincy Samuel practice?
Dr. Gincy Samuel practices at 6080 N Central Expy Ste 100, Dallas, TX 752065202. Office phone: 2148273610.
What is Dr. Gincy Samuel's NPI?
Dr. Gincy Samuel's National Provider Identifier (NPI) is 1821298399, issued by NPPES.
Does Dr. Gincy Samuel accept Medicare assignment?
Yes. Dr. Gincy Samuel accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gincy Samuel commonly perform?
Top Medicare-reported procedures in 2023: Injection, onabotulinumtoxina, 1 unit (HCPCS J0585); Injection, gadoterate meglumine, 0.1 ml (HCPCS A9575); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.